article · 2007
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial
32 citationsDOI: https://doi.org/10.1007/s00198-007-0505-y
Article
Article detail, metadata, authors, and available full-text links.
Paper reader
Loading paper...